Mateusz Tos

Katowice, SL, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Large language models as a screening tool for the qualification of patients with Parkinson's disease for device-aided therapies.

Large language models as a screening tool for the qualification of patients with Parkinson's disease for device-aided therapies.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: May 31, 2026

Successful use of continuous subcutaneous Foslevodopa/Foscarbidopa in Parkinson's disease with bipolar disorder without psychiatric destabilization.

Successful use of continuous subcutaneous Foslevodopa/Foscarbidopa in Parkinson's disease with bipolar disorder without psychiatric destabilization.

Journal: Clinical parkinsonism & related disorders

Published: April 19, 2026

Infusion therapies for advanced Parkinson's disease: current evidence and practical challenges - a narrative review.

Infusion therapies for advanced Parkinson's disease: current evidence and practical challenges - a narrative review.

Journal: Neurologia i neurochirurgia polska

Published: November 30, 2025

Idiopathic Hypertrophic Pachymeningitis with Elevated Anti-Thyroglobulin Antibodies-A Case Report.

Idiopathic Hypertrophic Pachymeningitis with Elevated Anti-Thyroglobulin Antibodies-A Case Report.

Journal: Reports (MDPI)

Published: November 23, 2025

Uric Acid and Impulse Control Disorders in Parkinson's Disease: A Cross-Sectional Analysis.

Uric Acid and Impulse Control Disorders in Parkinson's Disease: A Cross-Sectional Analysis.

Journal: Medicina (Kaunas, Lithuania)

Published: August 28, 2025

New-onset psychotic symptoms following continuous dopaminergic stimulation with subcutaneous foslevodopa/foscarbidopa.

New-onset psychotic symptoms following continuous dopaminergic stimulation with subcutaneous foslevodopa/foscarbidopa.

Journal: Neurologia i neurochirurgia polska

Published: July 05, 2025

Late-onset myelin oligodendrocyte glycoprotein antibody-associated disease: an underrecognized entity in clinical practice; what does its course in later life teach us? A case report and narrative review.

Late-onset myelin oligodendrocyte glycoprotein antibody-associated disease: an underrecognized entity in clinical practice; what does its course in later life teach us? A case report and narrative review.

Journal: Postepy psychiatrii neurologii

Published: May 10, 2025

The Relationship Between Autoimmune Disorders and Multiple Sclerosis: Clinical Insights and Therapeutic Approaches.

The Relationship Between Autoimmune Disorders and Multiple Sclerosis: Clinical Insights and Therapeutic Approaches.

Journal: Brain sciences

Published: May 09, 2025

Validation of the Polish version of the Movement Disorder Society Non-motor Rating Scale (MDS-NMS).

Validation of the Polish version of the Movement Disorder Society Non-motor Rating Scale (MDS-NMS).

Journal: Neurologia i neurochirurgia polska

Published: March 09, 2025

Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes-Is There a Difference?

Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes-Is There a Difference?

Journal: Brain sciences

Published: January 22, 2024

Impulse Control Disorders in the Polish Population of Patients with Parkinson's Disease.

Impulse Control Disorders in the Polish Population of Patients with Parkinson's Disease.

Journal: Medicina (Kaunas, Lithuania)

Published: July 11, 2023

The Influence of Serum Uric Acid Level on Non-Motor Symptoms Occurrence and Severity in Patients with Idiopathic Parkinson's Disease and Atypical Parkinsonisms-A Systematic Review.

The Influence of Serum Uric Acid Level on Non-Motor Symptoms Occurrence and Severity in Patients with Idiopathic Parkinson's Disease and Atypical Parkinsonisms-A Systematic Review.

Journal: Medicina (Kaunas, Lithuania)

Published: August 12, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026